4//SEC Filing
VATH JAMES E PHD 4
Accession 0001033025-03-000005
CIK 0001033025other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 7:11 PM ET
Size
6.8 KB
Accession
0001033025-03-000005
Insider Transaction Report
Form 4
VATH JAMES E PHD
Senior VP, Research
Transactions
- Award
Stock Option (Right to Buy)
2003-07-01+12,500→ 12,500 totalExercise: $4.90From: 2004-07-01Exp: 2013-07-01→ Common Stock, par value $.01 per share (12,500 underlying)
Holdings
- 2,412
Common Stock, par value $.01 per share
Footnotes (2)
- [F1]The term of the option is ten years from the date of grant.
- [F2]These options vest and become exercisable over a five-year period. Options with respect to 20% of the shares vest and become exercisable on 07/01/2004, and options with respect to the remaining shares vest and become exercisable in equal monthly installments thereafter. These options shall vest and become immediately exercisable in the event that the recipient is terminated in connection with a change of control of the Company.
Documents
Issuer
PRAECIS PHARMACEUTICALS INC
CIK 0001033025
Entity typeother
Related Parties
1- filerCIK 0001216416
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 7:11 PM ET
- Size
- 6.8 KB